scorecardresearch
Wednesday, July 23, 2025
TopicDGCI

Topic: DGCI

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

Tough pill to swallow for e-pharmacies as govt’s draft bill proposes curbs on online sale of drugs

Likely to be presented to Cabinet before being tabled in Parliament, latest version of draft bill aims to regulate, restrict or ban online sale of prescription drugs.

Texas hospital’s Covid-19 vaccine Corbevax is ‘not for profit’. It’s a ‘gift to the world’

In a statement, Biological E. said it plans to manufacture 75 million doses a month, anticipating more than 100 million doses per month by February 2022.

France’s Sanofi seeks marketing nod for dengue vaccine, govt panel says identify endemic areas

The vaccine Dengvaxia has to be administered to individuals aged 9 to 45, who have been infected with the dengue virus before and who live in areas where this infection is endemic.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

Drug regulator sends notice to Serum Institute over AstraZeneca vaccine trial

DCGI issued a show-cause notice to Serum Institute following reports that human trials of the Oxford vaccine were paused in UK after a candidate had an adverse reaction.

Health ministry asks DGCI to ensure equitable distribution of Remdesivir, Tocilizumab

The ministry wrote to DCGI, asking it to ascertain how many states, UTs have been covered and which of them are left, as far as the availability and distribution is concerned.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.